3-81594016-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000158.4(GBE1):āc.1000A>Gā(p.Ile334Val) variant causes a missense change. The variant allele was found at a frequency of 0.972 in 1,505,534 control chromosomes in the GnomAD database, including 711,835 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_000158.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBE1 | NM_000158.4 | c.1000A>G | p.Ile334Val | missense_variant | 8/16 | ENST00000429644.7 | NP_000149.4 | |
GBE1 | XR_007095662.1 | n.1128A>G | non_coding_transcript_exon_variant | 8/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GBE1 | ENST00000429644.7 | c.1000A>G | p.Ile334Val | missense_variant | 8/16 | 1 | NM_000158.4 | ENSP00000410833.2 | ||
GBE1 | ENST00000489715.1 | c.877A>G | p.Ile293Val | missense_variant | 8/16 | 2 | ENSP00000419638.1 |
Frequencies
GnomAD3 genomes AF: 0.979 AC: 148874AN: 152116Hom.: 72872 Cov.: 31
GnomAD3 exomes AF: 0.976 AC: 178058AN: 182518Hom.: 86882 AF XY: 0.974 AC XY: 94272AN XY: 96810
GnomAD4 exome AF: 0.972 AC: 1314913AN: 1353300Hom.: 638906 Cov.: 20 AF XY: 0.971 AC XY: 653309AN XY: 672632
GnomAD4 genome AF: 0.979 AC: 148990AN: 152234Hom.: 72929 Cov.: 31 AF XY: 0.978 AC XY: 72803AN XY: 74416
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Glycogen storage disease, type IV Benign:3
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Pars Genome Lab | Jun 15, 2021 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Aug 28, 2019 | - - |
Adult polyglucosan body disease Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Pars Genome Lab | Jun 15, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Glycogen storage disease, type IV;C1856301:Glycogen storage disease IV, classic hepatic Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at